We all know which stocks have made Wall Street's Buy List. What I want to know -- and I'm guessing you do, too -- is who's doing the buying. Which funds are buying Wall Street's most popular stocks ... and how does their judgment compare with that of our Motley Fool CAPS community?

Here's our latest group of contenders:


Last closing price

CAPS rating (out of 5)

First Cash Financial Services (Nasdaq: FCFS)



Akeena Solar



Tessera Technologies



Standard Pacific






Sources: Motley Fool CAPS, Yahoo! Finance.

Pawnshop and payday lender First Cash Financial has plenty of fund fans. But only one gets the five-star treatment from Morningstar.

Allow me to introduce you to CMG Small Cap Growth (COSCX), a no-load winner whose relatively new team -- top managers Wayne Collette and George Myers took over in February 2006 -- is off to a strong start. Small Cap Growth outpaced category peers by five percentage points in 2006 and more than 14 points last year.

Here's a look at the top five domestic stocks Collette, Myers, and team own today:


Last closing price

CAPS rating (out of 5)

ICON (Nasdaq: ICLR)



Hologic (Nasdaq: HOLX)



Vocus (Nasdaq: VOCS)



CF Industries (NYSE: CF)



SBA Communications



Sources: Morningstar, Motley Fool CAPS.

Talk about some interesting choices. More than 500 Fools have given medical-device maker Hologic the thumbs-up in CAPS. A modest 1.14 PEG ratio based on projected 2008 earnings per share speaks well for their choice.

But, of these five, I like contract researcher ICON. Medical science is advancing at a blistering pace, and establishing excellent processes for clinical trials, while necessary, can be both expensive and time-consuming. Outsourcing this function when appropriate makes sense.

As it does in other industries. Flextronics (Nasdaq: FLEX) has thrived as computer manufacturers have outsourced manufacturing and assembly. Taiwan Semiconductor (NYSE: TSM) has enjoyed success by building and mass-producing chips for budding designers.

And here's the best part: ICON is cheap. CAPS investor dollarpimp explained the rationale in this pitch from January. Quoting:

Discounted earnings valuation assuming 25% earnings growth over 10 years indicates this stock is selling at a substantial discount. Even assuming 20%, it's fairly priced. Just backed off a new high, buying on the dip. Healthcare sector will outperform.

Agreed. But I'm even more interested in what you think. Would you own ICON, or any of the stocks in CMG Small Cap Growth's portfolio, at today's prices? Log into CAPS today and let us know what you think. It's 100% free to participate.

If you like seeing what superior stock pickers are buying, consider Motley Fool Champion Funds. Its market-beaters are up 18 percentage points on their respective benchmarks. Examine the entire portfolio with a free, no-risk trial.

Fool contributor Tim Beyers, who is ranked 15,128 out of more than 96,000 participants in CAPS, owned shares of Taiwan Semiconductor at the time of publication. First Cash Financial is a Motley Fool Hidden Gems Pay Dirt recommendation. Check out Tim's portfolio and his latest blog commentary. The Fool's disclosure policy has recurring fantasies about a desert island, margaritas, and a plate of burritos. Go figure.